Costabile G, Conte G, Brusco S, Savadi P, Miro A, Quaglia F
Pharmaceutics. 2024; 16(3).
PMID: 38543241
PMC: 10975237.
DOI: 10.3390/pharmaceutics16030347.
Lee R, Mascenik T, Major S, Galiger J, Bulik-Sullivan E, Siesser P
Am J Physiol Lung Cell Mol Physiol. 2023; 326(3):L226-L238.
PMID: 38150545
PMC: 11280688.
DOI: 10.1152/ajplung.00421.2022.
Le Gall T, Berchel M, Davies L, Mottais A, Ghanem R, Fautrel A
Pharmaceutics. 2022; 14(1).
PMID: 35056921
PMC: 8778791.
DOI: 10.3390/pharmaceutics14010025.
Lee J, Cho A, Huang E, Xu Y, Quach H, Hu J
J Transl Med. 2021; 19(1):452.
PMID: 34717671
PMC: 8556969.
DOI: 10.1186/s12967-021-03099-4.
Zhong W, Zhang X, Zeng Y, Lin D, Wu J
Nano Res. 2021; 14(7):2067-2089.
PMID: 33456721
PMC: 7796694.
DOI: 10.1007/s12274-020-3180-3.
Emerging technologies for cystic fibrosis transmembrane conductance regulator restoration in all people with CF.
Egan M
Pediatr Pulmonol. 2020; 56 Suppl 1:S32-S39.
PMID: 32681713
PMC: 8114183.
DOI: 10.1002/ppul.24965.
Mutation-Directed Therapeutics for Neurofibromatosis Type I.
Leier A, Bedwell D, Chen A, Dickson G, Keeling K, Kesterson R
Mol Ther Nucleic Acids. 2020; 20:739-753.
PMID: 32408052
PMC: 7225739.
DOI: 10.1016/j.omtn.2020.04.012.
Intratracheal aerosolization of viral vectors to newborn pig airways.
Cooney A, Sinn P
Biotechniques. 2020; 68(5):235-239.
PMID: 32141776
PMC: 7252491.
DOI: 10.2144/btn-2019-0150.
The Development of Functional Non-Viral Vectors for Gene Delivery.
Patil S, Gao Y, Lin X, Li Y, Dang K, Tian Y
Int J Mol Sci. 2019; 20(21).
PMID: 31690044
PMC: 6862238.
DOI: 10.3390/ijms20215491.
Current Practices and Potential Nanotechnology Perspectives for Pain Related to Cystic Fibrosis.
Trandafir L, Leon M, Frasinariu O, Baciu G, Dodi G, Cojocaru E
J Clin Med. 2019; 8(7).
PMID: 31336857
PMC: 6678759.
DOI: 10.3390/jcm8071023.
Cystic Fibrosis Gene Therapy: Looking Back, Looking Forward.
Cooney A, McCray Jr P, Sinn P
Genes (Basel). 2018; 9(11).
PMID: 30405068
PMC: 6266271.
DOI: 10.3390/genes9110538.
Clinical Evaluations of Toxicity and Efficacy of Nanoparticle-Mediated Gene Therapy.
Liang X, Liu L, Wei Y, Gao G, Wei X
Hum Gene Ther. 2018; 29(11):1227-1234.
PMID: 29893153
PMC: 6909678.
DOI: 10.1089/hum.2018.069.
Targeted Integration of a Super-Exon into the CFTR Locus Leads to Functional Correction of a Cystic Fibrosis Cell Line Model.
Bednarski C, Tomczak K, Vom Hovel B, Weber W, Cathomen T
PLoS One. 2016; 11(8):e0161072.
PMID: 27526025
PMC: 4985144.
DOI: 10.1371/journal.pone.0161072.
Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
Lee T, Southern K, Perry L, Penny-Dimri J, Aslam A
Cochrane Database Syst Rev. 2016; (6):CD005599.
PMID: 27314455
PMC: 8682957.
DOI: 10.1002/14651858.CD005599.pub5.
Cystic fibrosis.
Ratjen F, Bell S, Rowe S, Goss C, Quittner A, Bush A
Nat Rev Dis Primers. 2016; 1:15010.
PMID: 27189798
PMC: 7041544.
DOI: 10.1038/nrdp.2015.10.
New and Emerging Treatments for Cystic Fibrosis.
Barry P, Jones A
Drugs. 2015; 75(11):1165-75.
PMID: 26091951
DOI: 10.1007/s40265-015-0424-8.
Non viral vectors in gene therapy- an overview.
Ramamoorth M, Narvekar A
J Clin Diagn Res. 2015; 9(1):GE01-6.
PMID: 25738007
PMC: 4347098.
DOI: 10.7860/JCDR/2015/10443.5394.
Unfolding the promise of translational targeting in neurodegenerative disease.
Drake T
Neuromolecular Med. 2015; 17(2):147-57.
PMID: 25697885
DOI: 10.1007/s12017-015-8346-x.
Ferret and pig models of cystic fibrosis: prospects and promise for gene therapy.
Yan Z, Stewart Z, Sinn P, Olsen J, Hu J, McCray Jr P
Hum Gene Ther Clin Dev. 2015; 26(1):38-49.
PMID: 25675143
PMC: 4367511.
DOI: 10.1089/humc.2014.154.
The expanding role of aerosols in systemic drug delivery, gene therapy and vaccination: an update.
Laube B
Transl Respir Med. 2014; 2:3.
PMID: 25505695
PMC: 4215822.
DOI: 10.1186/2213-0802-2-3.
